Real-world Data of Nivolumab in Pre-treated NSCLC

CompletedOBSERVATIONAL
Enrollment

346

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2020

Conditions
Non Small Cell Lung Cancer
All Listed Sponsors
lead

Hellenic Cooperative Oncology Group

OTHER

NCT04713462 - Real-world Data of Nivolumab in Pre-treated NSCLC | Biotech Hunter | Biotech Hunter